Shoppers are willing to pay more for snacks labeled “healthy” by the FDA, highlighting the power of trusted food labels.
ANN ARBOR, Mich., March 22, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for ...
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be no exception to this rule, and with its arrival we ...
(Corrects paragraph 4 of Jan 16 story to remove reference to lowering "bad" cholesterol, Vascepa does not lower cholesterol) By Blake Brittain WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agr ...
Study finds FDA-backed "healthy" labels increase healthier snack purchases and price premiums, highlighting the commercial ...
During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...
Uncertainties about the benefits and harms of new drugs are common at the time of drugs’ approval. It is unclear to what extent the Food and Drug Administration (FDA) communicates these uncertainties ...
WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's (AMRN.O), opens new tab cardiovascular drug Vascepa that could have broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results